Vaccine maker Sumagen Co. Ltd has launched a cGMP manufacturing partnership with French Naobios SAS for clinical testing of Sumagen’s inactivated HIV vaccine candidate.
https://european-biotechnology.com/wp-content/uploads/2024/04/HIV_.jpeg8601157Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-04-17 07:17:002024-06-13 13:31:15Naobios and Sumagen partner to develop HIV vaccine